Valuation: Henan Lingrui Pharmaceutical Co., Ltd.

Capitalization 12.4B 1.82B 1.55B 1.42B 1.34B 2.5B 172B 2.52B 16.81B 6.55B 82.69B 6.84B 6.69B 285B P/E ratio 2026 *
14.8x
P/E ratio 2027 * 13.4x
Enterprise value 12.29B 1.81B 1.54B 1.41B 1.33B 2.47B 171B 2.5B 16.67B 6.5B 81.98B 6.78B 6.64B 283B EV / Sales 2026 *
2.92x
EV / Sales 2027 * 2.66x
Free-Float
77.12%
Yield 2026 *
5.45%
Yield 2027 * 5.91%
1 day-0.81%
1 week-1.57%
Current month-1.57%
1 month+0.50%
3 months-0.63%
6 months-2.61%
Current year+6.28%
1 week 21.96
Extreme 21.96
22.43
1 month 21
Extreme 21
22.93
Current year 20.73
Extreme 20.73
22.93
1 year 20.3
Extreme 20.3
24.94
3 years 14.3
Extreme 14.3
27.26
5 years 9.2
Extreme 9.2
27.26
10 years 6.81
Extreme 6.81
27.26
Manager TitleAgeSince
Chief Executive Officer 42 2014-06-05
Director of Finance/CFO 57 2020-06-05
Corporate Officer/Principal 53 -
Director TitleAgeSince
Chairman 42 2019-04-28
Director/Board Member 55 2020-06-04
Director/Board Member 62 2006-04-17
Change 5d. change 1-year change 3-years change Capi.($)
-0.81%-1.57%-5.50%+33.56% 1.82B
+0.04%-0.81%-7.78%-8.66% 13.81B
+0.47%-0.18%-24.22%-54.05% 5.59B
+0.47%-2.44%-3.77%+4.09% 5.07B
+1.05%+1.70%+25.04%-39.89% 4.26B
+0.50%+4.04%+41.46%-11.07% 4.2B
+0.92%+3.36%+6.39%-6.50% 3.88B
0.00%-1.19%-2.86%+0.40% 3.28B
-0.50%-1.23%+1.64%-24.26% 2.49B
+0.17%+1.19%-5.89%-1.75% 1.93B
Average +0.23%+0.16%+2.45%-10.81% 4.63B
Weighted average by Cap. +0.29%-0.44%+0.37%-13.90%

Financials

2026 *2027 *
Net sales 4.21B 620M 526M 482M 455M 848M 58.52B 856M 5.72B 2.23B 28.11B 2.32B 2.28B 97.05B 4.56B 671M 570M 522M 493M 919M 63.38B 927M 6.19B 2.41B 30.45B 2.52B 2.46B 105B
Net income 846M 124M 106M 96.73M 91.3M 170M 11.75B 172M 1.15B 447M 5.64B 467M 457M 19.48B 931M 137M 116M 106M 100M 187M 12.93B 189M 1.26B 492M 6.21B 514M 503M 21.44B
Net Debt -106M -15.59M -13.24M -12.12M -11.44M -21.34M -1.47B -21.53M -144M -56.04M -707M -58.48M -57.25M -2.44B -249M -36.61M -31.11M -28.47M -26.87M -50.12M -3.46B -50.57M -338M -132M -1.66B -137M -134M -5.73B
Logo Henan Lingrui Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd is a China-based company, principally engaged in the research and development, production and distribution of medicines. The Company's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The Company distributes its products throughout China, with Henan Province and Beijing as its major markets.
Employees
2,435
Date Price Change Volume
26-05-08 22.01 ¥ -0.81% 5,500,994
26-05-07 22.19 ¥ 0.00% 7,297,950
26-05-06 22.19 ¥ -0.76% 10,715,040
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
22.01CNY
Average target price
27.90CNY
Spread / Average Target
+26.76%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600285 Stock